U.S. Markets closed

Allergan (AGN) in Focus: Stock Moves 6.2% Higher

Zacks Equity Research

Allergan plc AGN was a big mover last session, as the company saw its shares rise more than 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $115.73 –$139.51 in the past one-month time frame, witnessed a sharp increase yesterday.

The company's Zacks Consensus Estimate for the current quarter has moved higher over the past few weeks, suggesting that more solid trading could be ahead for Tailored Brands. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.

Allergan currently has a Zacks Rank #3 (Hold) while its Earnings ESP is positive.

Allergan plc Price

Allergan plc Price

Allergan plc price | Allergan plc Quote

Investors interested in the Medical – Genetics Drugs industry may consider Adamas Pharmaceuticals, Inc. ADMS, which has a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Is AGN going up? Or down? Predict to see what others think:Up or Down

Will you retire a millionaire?
One out of every six people retires a multimillionaire. Get smart tips you can do today to become one of them in a new Special Report, “7 Things You Can Do Now to Retire a Multimillionaire.”
Click to get it free >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Allergan plc (AGN) : Free Stock Analysis Report
Adamas Pharmaceuticals, Inc. (ADMS) : Free Stock Analysis Report
To read this article on Zacks.com click here.